about
Prostaglandin E2 signals through PTGER2 to regulate sclerostin expressionSost down-regulation by mechanical strain in human osteoblastic cells involves PGE2 signaling via EP4T lymphocytes amplify the anabolic activity of parathyroid hormone through Wnt10b signalingControl of the SOST bone enhancer by PTH using MEF2 transcription factorsDistinct modes of inhibition by sclerostin on bone morphogenetic protein and Wnt signaling pathwaysEffects of PTH on osteocyte functionThe amazing osteocyteOncostatin M promotes bone formation independently of resorption when signaling through leukemia inhibitory factor receptor in miceThe osteocyte: key player in regulating bone turnoverCatabolic and anabolic actions of parathyroid hormone on the skeletonThe osteocyte as a therapeutic target in the treatment of osteoporosisControl of bone mass and remodeling by PTH receptor signaling in osteocytesParathyroid Hormone Induces Bone Cell Motility and Loss of Mature Osteocyte Phenotype through L-Calcium Channel Dependent and Independent MechanismsLRP5 and LRP6 in development and diseaseRegulation of Wnt/β-catenin signaling within and from osteocytesWhere Wnts went: the exploding field of Lrp5 and Lrp6 signaling in boneLoad regulates bone formation and Sclerostin expression through a TGFβ-dependent mechanismEffects of dietary phosphate on adynamic bone disease in rats with chronic kidney disease--role of sclerostin?Parathyroid hormone signaling through low-density lipoprotein-related protein 6Interleukin-18 is regulated by parathyroid hormone and is required for its bone anabolic actionsPTH stimulates bone formation in mice deficient in Lrp5Single-pulsed electromagnetic field therapy increases osteogenic differentiation through Wnt signaling pathway and sclerostin downregulation.FGF-21 and skeletal remodeling during and after lactation in C57BL/6J mice.The reaction of bone to tumor growth from human breast cancer cells in a rat spine single metastasis model.Developments in sclerostin biology: regulation of gene expression, mechanisms of action, and physiological functions.Parathyroid hormone: anabolic and catabolic actions on the skeletonUpdate in new anabolic therapies for osteoporosisSerum sclerostin levels negatively correlate with parathyroid hormone levels and free estrogen index in postmenopausal women.Periosteal PTHrP regulates cortical bone modeling during linear growth in mice.Role of TGF-β in a mouse model of high turnover renal osteodystrophy.Osteocyte Wnt/beta-catenin signaling is required for normal bone homeostasisHypoxia decreases sclerostin expression and increases Wnt signaling in osteoblastsParathyroid hormone receptor signaling induces bone resorption in the adult skeleton by directly regulating the RANKL gene in osteocytes.The effect of renal dysfunction on circulating sclerostin level in patients with type 2 diabetes.Osteoblast-specific expression of the fibrous dysplasia (FD)-causing mutation Gsα(R201C) produces a high bone mass phenotype but does not reproduce FD in the mouse.Insulin like growth factor-I: a critical mediator of the skeletal response to parathyroid hormoneSclerostin: current knowledge and future perspectives.Osteocyte-derived RANKL is a critical mediator of the increased bone resorption caused by dietary calcium deficiency.T cells: critical bone regulators in health and disease.The immune system and bone.
P2860
Q21560844-5CF64B6E-BB90-4A3F-BF60-C5DCFB520F26Q24309550-D9187970-0298-4960-B33D-9D6D34E619E0Q24311640-D679C703-C8FC-44D5-8AAD-894F42345AA3Q24337339-F3A375F3-9A0C-462C-BEBC-8D00DD5BDB42Q24621990-381E62AA-B615-4B4A-BE48-20C6DC4F76CDQ24631082-7E4CBBC5-3160-4B3B-B5B4-800902F0193DQ24635849-36A4EB30-60DB-4057-B2F6-E273A0F6F7CAQ24642117-2F83099D-D260-4971-9C27-6F44FAD747DCQ26777912-66A0397D-9FCA-4728-AE43-E51A82849BCBQ26828873-51BD1182-8524-4D80-957F-96A242F09759Q27009129-E7697150-793E-44D6-8B14-F30486966540Q27300741-5FF0ECBB-158F-4AD9-8ABD-984ADB5784E3Q27308118-5DBFDEE1-12ED-4E2E-BFE2-76C60B70FA5AQ27692072-943CDD24-48CA-4529-861A-76CC09A6C0DFQ28286814-C7BEB3DD-F324-44AD-BAB2-1DE708F1CD0AQ28303536-6EB8C809-C561-49F8-AABF-9C6BC45434E8Q28484880-66AC62A0-BA42-4A54-8291-521328D25B65Q28535084-51A8CA89-8910-4CA4-802A-7E163F7689C3Q28567926-27A36DCD-D817-46A9-8C4E-BB5A3D1474DDQ28580087-D22183F0-CA17-41F7-B9DC-251C1A2F8DB2Q28592421-EC09D5B3-198F-45B3-95C1-8D8CA817CE46Q30278695-A81ACF68-FA0C-4874-B3A2-6DB753BC0055Q30371088-001BDE02-D7E8-4756-98F2-665C6982ADE6Q30415248-C76E1B6C-898E-4BFA-8F93-64D1E9FBA82FQ33564617-64A94188-F103-4119-BAAE-5C0DC02660F8Q33609126-952EC62B-2EAB-4B5D-8B9E-87BEE97D9B6DQ33786824-817560EE-38F8-44E6-9D54-705946169320Q33786865-83EA1815-40F7-466C-B7C4-D2372058A588Q33814335-46630C36-4CCB-425F-98D6-513F9144E686Q33827652-1B61E170-CA52-44C7-8313-D06FCB7B93A7Q33877602-49348C8C-8439-416D-8F6E-FF474AA2DD17Q33895465-45FA9DCC-BCF6-41C0-95F7-604CDF0ABEA0Q33901231-85A11149-9E2F-4D1E-B50A-ED02C560CF3EQ33905129-BCACF586-B727-4DE9-9B46-76A45405435DQ33926385-45D3FD10-9EDF-4678-9004-F5012F2E56B3Q33970422-E60AA22B-DA53-4091-942C-F95D2E0EC80DQ33992612-1B00CCBD-4986-43A5-9C69-A8E982205493Q34017216-01732D01-F620-45E4-A907-3CA9D71CAA19Q34079698-2BB1D40C-C76B-43AB-B2ED-A5C56FC66E0EQ34143343-6D2B8EE5-F328-4234-B1F0-8174CC5A6413
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
SOST is a target gene for PTH in bone.
@en
type
label
SOST is a target gene for PTH in bone.
@en
prefLabel
SOST is a target gene for PTH in bone.
@en
P1433
P1476
SOST is a target gene for PTH in bone.
@en
P2093
Hansjoerg Keller
Michaela Kneissel
P304
P356
10.1016/J.BONE.2005.03.018
P577
2005-08-01T00:00:00Z